Myometrial Progesterone Responsiveness

ABSTRACT

Progesterone actions in human pregnancy are controlled by the extent of myometrial progesterone responsiveness. Current progress in unraveling the biochemistry for myometrial progesterone responsiveness at the genomic and nongenomic levels have lead to novel hypotheses regarding the role of these pathways in the hormonal control of human pregnancy and parturition. For the genomic pathway, progesterone interacts with the type-B nuclear progesterone receptor (nPR-B), which decreases expression of contraction-associated genes. For the nongenomic pathway, progesterone interacts with membrane-associated PRs (mPRs) to modulate directly intracellular Ca²⁺ and cyclic adenosine monophosphate (cAMP) levels. During most of human pregnancy the genomic and nongenomic pathway cooperate to maintain myometrial relaxation. However, at parturition the relaxing actions of progesterone are nullified by changes in myometrial progesterone responsiveness. This occurs by (1) increased expression of the nPR variants (e.g., PR-A and/or PR-C) and changes in nPR coregulator levels that together repress the transcriptional activity of PR-B; and (2) increased expression of specific mPRs, especially mPRß, which augments contractility by decreasing intracellular cAMP. Functional progesterone withdrawal may be induced by locally produced prostaglandins that alter myometrial nPR expression. This may be an important physiological link between the control of parturition and the immune/inflammatory process.

KEYWORDS

Progesterone responsiveness - myometrium - human pregnancy - genomic - nongenomic

REFERENCES

• 1 Corner G W. The hormones in human reproduction. London; Princeton University Press 1946
• 2 Csapo A. Progesterone “block”.  Am J Anat. 1956;  98 273-292
• 3 Boroditsky R S, Reyes F I, Winter J S, Faiman C. Maternal serum estrogen and progesterone concentrations preceding normal labor.  Obstet Gynecol. 1978;  51 686-691
• 4 Tulchinsky D, Hobel C J, Yeager E, Marshall J R. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy.  Am J Obstet Gynecol. 1972;  112 1095-1100
• 5 Walsh S W, Stanczyk F Z, Novy M J. Daily hormonal changes in the maternal, fetal, and amniotic fluid compartments before parturition in a primate species.  J Clin Endocrinol Metab. 1984;  58 629-639
• 6 Tsai M-J, Clark J H, Schrader W T, O'Malley B W. Mechanisms of action of hormones that act as transcription-regulatory factors. In: Wilson J, Foster D, Kronenberg H, Larsen P Williams Textbook of Endocrinology. Philadelphia; WB Saunders 1998: 55-94
• 7 Jenuwein T, Allis C D. Translating the histone code.  Science. 2001;  293 1074-1080
• 8 Evans R M. The steroid and thyroid hormone receptor superfamily.  Science. 1988;  240 889-895
• 9 Evans R M. The nuclear receptor superfamily: a Rosetta stone for physiology.  Mol Endocrinol. 2005;  19 1429-1438
• 10 Mangelsdorf D J, Thummel C, Beato M et al.. The nuclear receptor superfamily: the second decade.  Cell. 1995;  83 835-839
• 11 Kastner P, Krust A, Turcotte B et al.. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.  EMBO J. 1990;  9 1603-1614
• 12 Hirata S, Shoda T, Kato J, Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans.  Trends Endocrinol Metab. 2003;  14 124-129
• 13 Giangrande P H, Kimbrel E A, Edwards D P, McDonnell D P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.  Mol Cell Biol. 2000;  20 3102-3115
• 14 Tung L, Mohamed M K, Hoeffler J P, Takimoto G S, Horwitz K B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.  Mol Endocrinol. 1993;  7 1256-1265
• 15 Vegeto E, Shahbaz M M, Wen D X et al.. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.  Mol Endocrinol. 1993;  7 1244-1255
• 16 Shyamala G, Yang X, Silberstein G, Barcellos-Hoff M H, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands.  Proc Natl Acad Sci USA. 1998;  95 696-701
• 17 Mulac-Jericevic B, Lydon J P, DeMayo F J, Conneely O M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.  Proc Natl Acad Sci USA. 2003;  100 9744-9749
• 18 Mulac-Jericevic B, Mullinax R A, DeMayo F J, Lydon J P, Conneely O M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform.  Science. 2000;  289 1751-1754
• 19 Giangrande P H, McDonnell D P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.  Recent Prog Horm Res. 1999;  54 291-313
• 20 Condon J C, Hardy D B, Kovaric K, Mendelson C R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function.  Mol Endocrinol. 2006;  20 764-775
• 21 Mesiano S, Chan E C, Fitter J T et al.. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium.  J Clin Endocrinol Metab. 2002;  87 2924-2930
• 22 Pieber D, Allport V C, Hills F, Johnson M, Bennett P R. Interaction between progesterone receptor isoforms in myometrial cells in human labour.  Mol Hum Reprod. 2001;  7 875-879
• 23 Haluska G J, Wells T R, Hirst J J et al.. Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition.  J Soc Gynecol Investig. 2002;  9 125-136
• 24 Henderson D, Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset.  Am J Obstet Gynecol. 2001;  185 579-585
• 25 Condon J C, Jeyasuria P, Faust J M, Wilson J W, Mendelson C R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition.  Proc Natl Acad Sci USA. 2003;  100 9518-9523
• 26 Dong X, Shylnova O, Challis J R, Lye S J. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor.  J Biol Chem. 2005;  280 13329-13340
• 27 Elger W, Hasan S G. Studies on the mechanism of action of antifertile PG in animal models.  Acta Physiol Hung. 1985;  65 415-432
• 28 Elger W, Hasan S H, Friedreich E. “Uterine” and “luteal” effects of prostaglandins (PG) in rats and guinea pigs as potential abortifacient mechanisms.  Acta Endocrinol Suppl (Copenh). 1973;  173 46
• 29 Sugimoto Y, Yamasaki A, Segi E et al.. Failure of parturition in mice lacking the prostaglandin F receptor.  Science. 1997;  277 681-683
• 30 Embrey M. PGE compounds for induction of labor and abortion.  Ann N Y Acad Sci. 1971;  180 518-523
• 31 Thiery J. Induction of labor with prostaglandins. In: Keirse M, Anderson A, Benebroek-Gravenhorst J Human Parturition. The Hague, the Netherlands; Martinus Nijhoff 1979: 155-164
• 32 Jain J K, Mishell Jr D R. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.  N Engl J Med. 1994;  331 290-293
• 33 Robins J, Mann L I. Midtrimester pregnancy termination by intramuscular injection of a 15-methyl analogue of prostaglandin F2 alpha.  Am J Obstet Gynecol. 1975;  123 625-631
• 34 Madsen G, Zakar T, Ku C Y et al.. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: evidence for prostaglandin-induced functional progesterone withdrawal.  J Clin Endocrinol Metab. 2004;  89 1010-1013
• 35 Mitchell M D, Romero R J, Edwin S S, Trautman M S. Prostaglandins and parturition.  Reprod Fertil Dev. 1995;  7 623-632
• 36 Meizel S, Turner K O. Progesterone acts at the plasma membrane of human sperm.  Mol Cell Endocrinol. 1991;  77 R1-R5
• 37 Meizel S, Turner K O, Nuccitelli R. Progesterone triggers a wave of increased free calcium during the human sperm acrosome reaction.  Dev Biol. 1997;  182 67-75
• 38 Turner K O, Garcia M A, Meizel S. Progesterone initiation of the human sperm acrosome reaction: the obligatory increase in intracellular calcium is independent of the chloride requirement.  Mol Cell Endocrinol. 1994;  101 221-225
• 39 Tian J, Kim S, Heilig E, Ruderman J V. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation.  Proc Natl Acad Sci USA. 2000;  97 14358-14363
• 40 McEwen B S. Non-genomic and genomic effects of steroids on neural activity.  Trends Pharmacol Sci. 1991;  12 141-147
• 41 Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology.  Trends Neurosci. 1990;  13 359-362
• 42 Perusquia M. Nongenomic action of steroids in myometrial contractility.  Endocrine. 2001;  15 63-72
• 43 Fomin V P, Cox B E, Word R A. Effect of progesterone on intracellular Ca2 + homeostasis in human myometrial smooth muscle cells.  Am J Physiol. 1999;  276 C379-C385
• 44 Perusquia M, Garcia-Yanez E, Ibanez R, Kubli-Garfias C. Non-genomic mechanism of action of delta-4 and 5-reduced androgens and progestins on the contractility of the isolated rat myometrium.  Life Sci. 1990;  47 1547-1553
• 45 Kofinas A D, Rose J C, Koritnik D R, Meis P J. Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity.  J Reprod Med. 1990;  35 1045-1050
• 46 Sager G, Orbo A, Jaeger R, Engstrom C. Non-genomic effects of progestins-inhibition of cell growth and increased intracellular levels of cyclic nucleotides.  J Steroid Biochem Mol Biol. 2003;  84 1-8
• 47 Grazzini E, Guillon G, Mouillac B, Zingg H H. Inhibition of oxytocin receptor function by direct binding of progesterone.  Nature. 1998;  392 509-512
• 48 Karteris E, Zervou S, Pang Y et al.. Progesterone signaling in human myometrium through two novel membrane G protein coupled receptors: potential role in functional progesterone withdrawal at term.  Mol Endocrinol. 2006;  7 1519-1534
• 49 Fu X, Moberg C, Backstrom T, Ulmsten U, Gylfe E. Anisomycin and verapamil influence the action of progesterone on regulation of term human myometrial contractile activity.  Clin Endocrinol (Oxf). 1997;  47 349-355
• 50 Rezapour M, Hongpaisan J, Fu X et al.. Effects of progesterone and oxytocin on intracellular elemental composition of term human myometrium in vitro.  Eur J Obstet Gynecol Reprod Biol. 1996;  68 191-197
• 51 Haukkamaa M. High affinity progesterone binding sites of human uterine microsomal membranes.  J Steroid Biochem. 1984;  20 569-573
• 52 Khan-Dawood F S, Dawood M Y. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy.  Am J Obstet Gynecol. 1984;  150 501-505
• 53 Astle S, Khan R N, Thornton S. The effects of a progesterone metabolite, 5 beta-dihydroprogesterone, on oxytocin receptor binding in human myometrial membranes.  BJOG. 2003;  110 589-592
• 54 Saner K J, Welter B H, Zhang F et al.. Cloning and expression of a novel, truncated, progesterone receptor.  Mol Cell Endocrinol. 2003;  200 155-163
• 55 Shah C, Modi D, Sachdeva G et al.. N-terminal region of progesterone receptor B isoform in human spermatozoa.  Int J Androl. 2005;  28 360-371
• 56 Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor.  Proc Natl Acad Sci USA. 2003;  100 2237-2242
• 57 Zhu Y, Rice C D, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes.  Proc Natl Acad Sci USA. 2003;  100 2231-2236
• 58 Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors.  Biol Chem. 1998;  379 907-911
• 59 Mifsud W, Bateman A. Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain.  Genome Biol. 2002;  3 RESEARCH68.1-68.5
• 60 Mourot B, Nguyen T, Fostier A, Bobe J. Two unrelated putative membrane-bound progestin receptors, progesterone membrane receptor component 1 (PGMRC1) and membrane progestin receptor (mPR) beta, are expressed in the rainbow trout oocyte and exhibit similar ovarian expression patterns.  Reprod Biol Endocrinol. 2006;  4 6-20
• 61 Fernandes M S, Pierron V, Michalovich D et al.. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues.  J Endocrinol. 2005;  187 89-101
• 62 Chapman N R, Kennelly M M, Harper K A, Europe-Finner G N, Robson S C. Examining the spatio-temporal expression of mRNA encoding the membrane-bound progesterone receptor-alpha isoform in human cervix and myometrium during pregnancy and labour.  Mol Hum Reprod. 2006;  12 19-24
• 63 da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.  Am J Obstet Gynecol. 2003;  188 419-424
• 64 Meis P J, Klebanoff M, Thom E et al.. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.  N Engl J Med. 2003;  348 2379-2385
• 65 Chanrachakul B, Pipkin F B, Warren A Y, Arulkumaran S, Khan R N. Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium.  Am J Obstet Gynecol. 2005;  192 458-463